Drugs / Bacillus of Calmette-Guerin (BCG)
last change Dec 2024 re-read 2 minutes ago

Bacillus of Calmette-Guerin (BCG)

Developed for
urinary bladder cancer
Investigated by
Australian and New Zealand Urogenital and Prostate Cancer Trials Group · Cancer Australia · University of Sydney

Trials 1 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02948543 Jul 2013 → Dec 2024 urinary bladder cancer University of Sydney Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bacillus of Calmette-Guerin (BCG) ClinicalTrials.gov intervention name — accepted as the source's own label NCT02948543